Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shreya Life Sciences' iron complex formulation is an injectable iron replacement therapy designed to treat iron deficiency anemia. The product consists of iron dextran, a complex of ferric hydroxide and a dextran polymer carrier, often formulated with additional dextran. This formulation acts as a reservoir for iron, which is slowly released and processed by the reticuloendothelial system to restore depleted iron stores. By providing a source of iron, the drug enables the synthesis of hemoglobin and the production of red blood cells. It is primarily indicated for patients with iron deficiency anemia who cannot tolerate or have not responded adequately to oral iron supplementation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dextran + iron dextran.